返回 Agenda
Session 6, Track B: Advancing Clinical Development with AI - Trends, Applications, and Lessons from the Field
Session Chair(s)
Stephanie Anderson, MS
Associate Director, Regulatory Affairs, Intrinsik Corp., Canada
Hocine Abid, MD, MBA
National Manager, Regulatory Operations and Enforcement Branch, Health Canada, Canada
Artificial intelligence is rapidly reshaping the clinical development landscape by creating new opportunities to accelerate research and to improve operational efficiency. AI-powered solutions have quickly moved from experimentation to real-world implementation, however there are severe ramifications with unsupervised automation and overreliance on these AI-tools for strategic decision-making. This session will explore the latest trends in AI adoption across clinical development, highlighting practical applications, case studies and lessons learned from deploying AI technologies in clinical development while employing strategies for scaling innovation responsibly.
Learning Objective : At the conclusion of this session, participants should be able to: - Define current AI trends shaping clinical development and detail their practical application
- Recognize risks associated with unsupervised AI use and overreliance in strategic decision-making
- Evaluate real-world AI use cases and their impact on research efficiency and trial operations
- Identify common challenges related to data quality, governance, and regulatory compliance
Speaker(s)
Evan Richardson, RAC
Sr. Director, Regulatory Operations & Clinical Disclosure, Veristat, United States
The Digital Chaperone: Why Your AI is a Brilliant Intern, Not a Science Savior